TearLab Corporation (TEAR)
-NasdaqCM 10.16 
0.76(8.09%) May 17, 4:00PM EDT
| Prev Close: | 9.40 |
|---|
| Open: | 9.50 |
|---|
| Bid: | 8.38 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 10.20 |
|---|
| Beta: | 2.41 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 9.44 - 10.20 |
|---|
| 52wk Range: | 2.75 - 10.20 |
|---|
| Volume: | 728,464 |
|---|
| Avg Vol (3m): | 339,219 |
|---|
| Market Cap: | 292.25M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.69 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Six longs in a resilient marketat MarketWatch(Wed, May 15)
- TearLab Beats on Both Top and Bottom Linesat Motley Fool(Wed, May 15)
- TEARLAB CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, May 14)
- TearLab's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, May 13)
- TearLab Corporation Reports Q1-13 Financial ResultsGlobeNewswire(Mon, May 13)
- Q1 2013 TearLab Corp Earnings Release - After Market CloseCCBN(Mon, May 13)
- TearLab: Here’s What Investors Need to Know Before Earningsat Wall St. Cheat Sheet(Sat, May 11)
- TearLab Corporation to Release Q1 2013 Financial Results on May 13, 2013GlobeNewswire(Mon, Apr 29)
- TearLab: Watch For A Sharp Drop On Equity Offeringat Seeking Alpha(Wed, Apr 24)
- TearLab Launches Free Smartphone Investor Relations AppGlobeNewswire(Tue, Apr 9)
- TEARLAB CORP FinancialsEDGAR Online Financials(Fri, Mar 29)
- TEARLAB CORP Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Mar 25)
- Sprint’s Clearwire Takeover Faces Opposition and 4 Stocks At 52-Week Highsat Wall St. Cheat Sheet(Thu, Mar 21)
- TearLab's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Mar 20)
- TearLab Corporation Reports 2012 Financial ResultsGlobeNewswire(Wed, Mar 20)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 44.97 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.46 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.11 |
|---|
| Mean Recommendation*: | 1.3 |
|---|
| PEG Ratio (5 yr expected): | -0.68 |
|---|
Business Summary
TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of d...
View More